DR Horton to rally nearly 15% due to booming housing market, Credit Suisse says

Investors should buy D.R. Horton shares because its entry-level housing business will thrive in the coming years, according to Credit Suisse, which initiated coverage on the home-builder with an outperform rating. “DR Horton is among the best positioned builders...